Legend Biotech appoints Ingrid Zhang as CEO; shares gain
15/09/2026 13:49
BUZZ-Legend Biotech appoints Ingrid Zhang as CEO; shares gain ** Shares of drugmaker Legend Biotech LEGN.O gain 2.6% to $19.02 in premarket trading
** Co appoints longtime Novartis NOVN.S executive Ingrid Zhang as CEO
** LEGN also says Alan Bash, who had been serving as interim CEO, will return to his role as president of the Carvykti business
** In August, co beat Q2 earnings estimates
** Eleven of 16 brokerages rate the stock "buy" or higher, five "hold"; their median PT is $56 — LSEG-compiled data
** Up to last day's close, shares are down 14.8% YTD
(Reporting by Sudeshna Ghoshal in Bengaluru)